Söndag 23 Februari | 22:48:11 Europe / Stockholm

Prenumeration

2025-02-14 09:57:00

Redeye makes positive revisions to its financial projections and fair value range following Stille's year-end report. The report confirmed 22% organic growth, an EBITDA margin of 28% (excluding the one-off impairment in the tables business), and a strong outlook for the company moving forward.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/